Adenocarcinoma of the anal canal - a systematic review
Aim The prognosis of anal adenocarcinoma is poor and the management remains controversial. We carried out a literature review to identify current practice in the management of anal adenocarcinoma. Method A systematic review of the literature was performed for studies in the English language publishe...
Saved in:
Published in | Colorectal disease Vol. 15; no. 12; pp. 1481 - 1488 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.12.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim
The prognosis of anal adenocarcinoma is poor and the management remains controversial. We carried out a literature review to identify current practice in the management of anal adenocarcinoma.
Method
A systematic review of the literature was performed for studies in the English language published between 1950 and 2011. All those that focused on the management of anal adenocarcinoma were considered for inclusion.
Results
Sixteen retrospective observational studies were identified; no randomized trials were found. Most of the studies contained small numbers of patients due to the rarity of anal adenocarcinoma. Treatment included local excision), radiotherapy, chemotherapy, chemoradiotherapy and abdominoperineal excision. Most studies concluded that a multimodality approach, combining radical surgical resection with neoadjuvant/adjuvant chemoradiotherapy was the optimal management strategy.
Conclusion
The prognosis of anal adenocarcinoma is poor, and there is little information on the optimal management. The relevant studies indicate that a combination of radical surgical resection and pre‐ or postoperative chemoradiotherapy offers the best chance of survival. |
---|---|
AbstractList | The prognosis of anal adenocarcinoma is poor and the management remains controversial. We carried out a literature review to identify current practice in the management of anal adenocarcinoma.
A systematic review of the literature was performed for studies in the English language published between 1950 and 2011. All those that focused on the management of anal adenocarcinoma were considered for inclusion.
Sixteen retrospective observational studies were identified; no randomized trials were found. Most of the studies contained small numbers of patients due to the rarity of anal adenocarcinoma. Treatment included local excision), radiotherapy, chemotherapy, chemoradiotherapy and abdominoperineal excision. Most studies concluded that a multimodality approach, combining radical surgical resection with neoadjuvant/adjuvant chemoradiotherapy was the optimal management strategy.
The prognosis of anal adenocarcinoma is poor, and there is little information on the optimal management. The relevant studies indicate that a combination of radical surgical resection and pre- or postoperative chemoradiotherapy offers the best chance of survival. AIMThe prognosis of anal adenocarcinoma is poor and the management remains controversial. We carried out a literature review to identify current practice in the management of anal adenocarcinoma.METHODA systematic review of the literature was performed for studies in the English language published between 1950 and 2011. All those that focused on the management of anal adenocarcinoma were considered for inclusion.RESULTSSixteen retrospective observational studies were identified; no randomized trials were found. Most of the studies contained small numbers of patients due to the rarity of anal adenocarcinoma. Treatment included local excision), radiotherapy, chemotherapy, chemoradiotherapy and abdominoperineal excision. Most studies concluded that a multimodality approach, combining radical surgical resection with neoadjuvant/adjuvant chemoradiotherapy was the optimal management strategy.CONCLUSIONThe prognosis of anal adenocarcinoma is poor, and there is little information on the optimal management. The relevant studies indicate that a combination of radical surgical resection and pre- or postoperative chemoradiotherapy offers the best chance of survival. Aim The prognosis of anal adenocarcinoma is poor and the management remains controversial. We carried out a literature review to identify current practice in the management of anal adenocarcinoma. Method A systematic review of the literature was performed for studies in the English language published between 1950 and 2011. All those that focused on the management of anal adenocarcinoma were considered for inclusion. Results Sixteen retrospective observational studies were identified; no randomized trials were found. Most of the studies contained small numbers of patients due to the rarity of anal adenocarcinoma. Treatment included local excision), radiotherapy, chemotherapy, chemoradiotherapy and abdominoperineal excision. Most studies concluded that a multimodality approach, combining radical surgical resection with neoadjuvant/adjuvant chemoradiotherapy was the optimal management strategy. Conclusion The prognosis of anal adenocarcinoma is poor, and there is little information on the optimal management. The relevant studies indicate that a combination of radical surgical resection and pre‐ or postoperative chemoradiotherapy offers the best chance of survival. Abstract Aim The prognosis of anal adenocarcinoma is poor and the management remains controversial. We carried out a literature review to identify current practice in the management of anal adenocarcinoma. Method A systematic review of the literature was performed for studies in the English language published between 1950 and 2011. All those that focused on the management of anal adenocarcinoma were considered for inclusion. Results Sixteen retrospective observational studies were identified; no randomized trials were found. Most of the studies contained small numbers of patients due to the rarity of anal adenocarcinoma. Treatment included local excision), radiotherapy, chemotherapy, chemoradiotherapy and abdominoperineal excision. Most studies concluded that a multimodality approach, combining radical surgical resection with neoadjuvant/adjuvant chemoradiotherapy was the optimal management strategy. Conclusion The prognosis of anal adenocarcinoma is poor, and there is little information on the optimal management. The relevant studies indicate that a combination of radical surgical resection and pre‐ or postoperative chemoradiotherapy offers the best chance of survival. |
Author | Anwar, S. Sebag-Montefiore, D. Hill, J. Welbourn, H. |
Author_xml | – sequence: 1 givenname: S. surname: Anwar fullname: Anwar, S. email: : Mr S. Anwar, Consultant General Surgeon, Calderdale and Huddersfield NHS Trust, Huddersfield Royal Infirmary, Lindley, Huddersfield HD3 3EA, UK., suanwar@btinternet.com organization: Department of Colorectal Surgery, Calderdale and Huddersfield NHS Trust, Huddersfield, UK – sequence: 2 givenname: H. surname: Welbourn fullname: Welbourn, H. organization: Department of Colorectal Surgery, Calderdale and Huddersfield NHS Trust, Huddersfield, UK – sequence: 3 givenname: J. surname: Hill fullname: Hill, J. organization: Department of Colorectal Surgery, Central Manchester University Hospitals, Manchester, UK – sequence: 4 givenname: D. surname: Sebag-Montefiore fullname: Sebag-Montefiore, D. organization: Department of Oncology, St James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23809885$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kE9PwjAYhxuDEVAvfgCzozEZru26dUcCgiREYoJ6bNruXazuD7ZD5Ns7GHC0h7aH5_d78z591CmrEhC6wcEAN-dBV6kZYEIJO0M9HEbUxxTzzv5PfJ7goIv6zn0GAY5izC9Ql1AeJJyzHoqGKZSVllabsiqkV2Ve_QGeLGXu6f3te9JzW1dDIWujPQs_BjZX6DyTuYPrw3uJXiePy9GTP19MZ6Ph3NchpczncaRJGkGkFVFhCqFu5magAqKIVDRhYSK5YjjLYkiimDCmJMeU4SCUVKWMXqK7tndlq-81uFoUxmnIc1lCtXai2RBTmsQ8adD7FtW2cs5CJlbWFNJuBQ7EzpPYeRJ7Tw18e-hdqwLSE3oU0wC4BTYmh-0_VWK0GM-OpX6bMY2t31NG2i8RxTRm4v15KsLxZPkSkzfB6B8vC4HB |
CitedBy_id | crossref_primary_10_1136_bmjgast_2021_000661 crossref_primary_10_17235_reed_2018_5657_2018 crossref_primary_10_1016_j_ctrc_2015_10_003 crossref_primary_10_1245_s10434_019_07202_4 crossref_primary_10_12998_wjcc_v10_i3_1122 crossref_primary_10_1155_2020_5139236 crossref_primary_10_1007_s00384_022_04211_w crossref_primary_10_1080_03007995_2018_1441817 crossref_primary_10_1016_j_ijrobp_2019_06_2544 crossref_primary_10_1097_DCR_0000000000001506 crossref_primary_10_1155_2018_4017043 crossref_primary_10_1016_j_suc_2020_02_007 crossref_primary_10_1097_MD_0000000000013877 crossref_primary_10_1186_s13000_015_0379_9 crossref_primary_10_3390_cancers14153738 crossref_primary_10_1038_s41416_018_0049_2 crossref_primary_10_1007_s12328_016_0688_x crossref_primary_10_2147_IMCRJ_S350999 crossref_primary_10_1097_DCR_0000000000001874 crossref_primary_10_1016_j_jcol_2018_08_001 crossref_primary_10_1111_1346_8138_13633 crossref_primary_10_1093_jscr_rjad334 crossref_primary_10_1158_1055_9965_EPI_15_0044 crossref_primary_10_1371_journal_pone_0219937 crossref_primary_10_1016_j_clcc_2020_04_001 crossref_primary_10_1093_ecco_jcc_jjx035 crossref_primary_10_1245_s10434_019_07466_w crossref_primary_10_1111_codi_17054 crossref_primary_10_1016_j_lpm_2018_05_009 crossref_primary_10_1016_j_ejcskn_2023_100002 crossref_primary_10_1016_j_ijscr_2019_03_019 crossref_primary_10_1007_s10863_019_09792_w crossref_primary_10_1016_j_suronc_2021_101551 crossref_primary_10_1093_ije_dyw276 crossref_primary_10_17235_reed_2023_9791_2023 crossref_primary_10_1007_s13126_017_0375_5 |
Cites_doi | 10.1007/BF02554358 10.1177/000313480306900218 10.1007/BF02053944 10.1002/(SICI)1097-0142(19970815)80:4<805::AID-CNCR20>3.0.CO;2-W 10.1016/S0002-9610(99)80143-3 10.1016/S0360-3016(99)00267-9 10.1002/ibd.21228 10.1111/j.1463-1318.2005.00934.x 10.1002/jso.2930230407 10.1001/archsurg.1957.01280150042005 10.1016/S0360-3016(02)04118-4 10.1016/S0360-3016(00)01540-6 10.1007/DCR.0b013e318197d0ad 10.1001/archsurg.1964.01320060057011 10.1177/014107688808100411 10.1136/gut.35.3.347 10.1007/s10350-004-6740-9 10.1136/jcp.49.12.1009 10.1016/S0360-3016(03)00277-3 10.1007/s11605-009-1061-x 10.1002/(SICI)1097-0142(19990415)85:8<1686::AID-CNCR7>3.0.CO;2-7 10.1097/PAT.0b013e328340e4d6 10.1007/DCR.0b013e3181a79589 10.1002/cncr.20364 10.1007/BF02237388 10.1002/(SICI)1096-9098(199703)64:3<218::AID-JSO8>3.0.CO;2-D |
ContentType | Journal Article |
Copyright | 2013 The Authors. Colorectal Disease © 2013 The Association of Coloproctology of Great Britain and Ireland 2013 The Authors. Colorectal Disease © 2013 The Association of Coloproctology of Great Britain and Ireland. |
Copyright_xml | – notice: 2013 The Authors. Colorectal Disease © 2013 The Association of Coloproctology of Great Britain and Ireland – notice: 2013 The Authors. Colorectal Disease © 2013 The Association of Coloproctology of Great Britain and Ireland. |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1111/codi.12325 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1463-1318 |
EndPage | 1488 |
ExternalDocumentID | 10_1111_codi_12325 23809885 CODI12325 ark_67375_WNG_4DFTQ72V_5 |
Genre | reviewArticle Journal Article Review |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OC 29F 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RX1 SUPJJ TEORI UB1 V8K V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4335-876c2d6e6cb2b4de4c809feb02b2ab39549a8b51ff7e967255ba8135104a3bd53 |
IEDL.DBID | DR2 |
ISSN | 1462-8910 |
IngestDate | Fri Aug 16 23:50:41 EDT 2024 Fri Aug 23 00:39:41 EDT 2024 Tue Aug 27 13:50:53 EDT 2024 Sat Aug 24 01:15:49 EDT 2024 Wed Oct 30 09:53:29 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | adenocarcinoma chemo radiotherapy abdominoperineal resection Anal |
Language | English |
License | 2013 The Authors. Colorectal Disease © 2013 The Association of Coloproctology of Great Britain and Ireland. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4335-876c2d6e6cb2b4de4c809feb02b2ab39549a8b51ff7e967255ba8135104a3bd53 |
Notes | ArticleID:CODI12325 ark:/67375/WNG-4DFTQ72V-5 istex:D81E249750E1D001E2A3FC1D65327FF3C5547E5C SourceType-Scholarly Journals-1 ObjectType-Feature-4 ObjectType-Undefined-1 content type line 23 ObjectType-Review-2 ObjectType-Article-3 |
PMID | 23809885 |
PQID | 1461339789 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1461339789 crossref_primary_10_1111_codi_12325 pubmed_primary_23809885 wiley_primary_10_1111_codi_12325_CODI12325 istex_primary_ark_67375_WNG_4DFTQ72V_5 |
PublicationCentury | 2000 |
PublicationDate | December 2013 |
PublicationDateYYYYMMDD | 2013-12-01 |
PublicationDate_xml | – month: 12 year: 2013 text: December 2013 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Colorectal disease |
PublicationTitleAlternate | Colorectal Dis |
PublicationYear | 2013 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | Neilson OV, Koch F. Carcinomas of the anorectal region of extramucosal origin with special reference to the anal ducts. Acta Chir Scand 1973; 139: 299-305. Beal KP, Wong D, Guillem JG et al. Primary adenocarcinoma of the anus treated with combined modality therapy. Dis Colon Rectum 2003; 46: 1320-4. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999; 85: 1686-93. Devon KM, Brown CJ, Burnstein M, McLeod RS. Cancer of the anus complicating perianal Crohn's disease. Dis Colon Rectum 2009; 52: 211-6. Thomas M, Bienkowski R, Vandermeer TJ, Trostle D, Cagir B. Malignant transformation in perianal fistulas of Crohn's disease: a systematic review of the literature. J Gastrointest Surg 2010; 14: 66-73. Wong MTC, Lim JF, Eu KW. Anal canal malignancies: a review in an Asian population. SMJ 2011; 52: 9-14. Schaffzin DM, Stahl TJ, Smith LE. Perianal mucinous adenocarcinoma: unusual case presentations and review of the literature. Am Surg 2003 Feb; 69: 166-9. Myerson RJ, Karnell LH, Menck HR. The National Cancer Data Base report on carcinoma of the anus. Cancer 1997; 80: 805-15. Ball CS, Wujanto R, Haboubi NY, Schofield PF. Carcinoma in anal Crohn's disease: discussion paper. J R Soc Med 1988; 81: 217-9. Sengul N, Wexner SD, Woodhouse S et al. Effects of radiotherapy on different histopathological types of rectal carcinoma. Colorectal Dis 2006; 8: 283-8. Wolff P, Peiffert D. In regard to Joon et al. IJROBP 1999;45:1199-1205. Int J Radiat Oncol Biol Phys 2001; 49: 1517. Buckwalter JA, Jurayj MN. Relationship of anorectal disease to carcinoma. Arch Surg 1957; 75: 352-61. Abel ME, Chiu YSY, Russell TR, Volpe PA. Adenocarcinoma of the anal glands: results of a survey. Dis Colon Rectum 1993; 36: 383-7. Nishigami T, Kataoka TR, Ikeuchi H et al. Adenocarcinomas associated with perineal fistulae in Crohn's disease have a rectal, not an anal, immunophenotype. Pathology 2011; 43: 36-9. Jensen SL, Shokouh-Amiri MH, Hagen K, Harling H, Nielsen OV. Adenocarcinoma of the anal ducts. A series of 21 cases. Dis Colon Rectum 1988; 31: 268-72. Li LR, Wan DS, Pan ZZ et al. Clinical features and treatment of 49 patients with anal canal adenocarcinoma. Chin J Gastrointest Surg 2006; 9: 402-4. Berg HK. Adenocarcinoma of the anal canal. Md Med J 1990; 39: 675-8. Belkacemi Y, Berger C, Poortmans P et al. Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2003; 56: 1274-83. Basik M, Rodriguez-Bigas MA, Penetrante R, Petrelli NJ. Prognosis and recurrence patterns of anal adenocarcinoma. Am J Surg 1995; 169: 233-7. Chang GJ, Gonzalez RJ, Skibber JM, Eng C, Das P, Rodriguez-Bigas MA. A twenty-year experience with adenocarcinoma of the anal canal. Dis Colon Rectum 2009; 52: 1375-80. Bosset JF, Calais G, Mineur L et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. Colorectal Dis 2006; 8: 283-8. Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Lennard-Jones JE. Lower gastrointestinal malignancy in Crohn's disease. Gut 1994; 35: 347-52. Behan WMH, Burnett RA. Adenocarcinoma of the anal glands. J Clin Pathol 1996; 49: 1009-11. Kline RJ, Spencer RJ, Harrison RG. Carcinoma associated with fistula in ano. Arch Surg 1964; 89: 989-94. Papagikos M, Crane CH, Skibber J et al. Chemoradiation for adenocarcinoma of the anus. Int J Radiat Oncol Biol Phys 2003; 55: 669-78. Iesalnieks I, Gaertner WB, Glass H, Strauch U, Hipp M, Schlitt HJ. Fistula-associated anal adenocarcinoma in Crohn's disease. Inflamm Bowel Dis 2010; 16: 1643-8. Anthony T, Simmang C, Lee EL, Turnage RH. Perinal mucinous adenocarcinoma. J Surg Oncol 1997; 64: 218-21. Longo WE, Vernava AM, Wade TP, Coplin MA, Virgo KS, Johnson FE. Rare anal canal cancers in the U.S. veteran: patterns of disease and results of treatment. Am Surg 1995; 61: 495-500. Joon DL, Chao MWT, Ngan SYK, Joon ML, Guiney MJ. Primary adenocarcinoma of the anus: a retrospective analysis. Int J Radiat Oncol Biol Phys 1999; 45: 1199-205. Zaren HA, Delone FX, Lerner HJ. Carcinoma of the anal gland: case report and review of the literature. J Surg Oncol 1983; 23: 250-4. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101: 281-8. Ky A, Sohn N, Weinstein MA, Korelitz BI. Carcinoma arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum 1998; 41: 992-6. 2004; 101 1997; 80 1957; 75 2010; 16 2010; 14 1990; 39 1997; 64 2006; 9 1999; 45 2011; 52 2006; 8 2001; 49 1999; 85 1964; 89 1988; 31 1998; 41 2003; 55 2003; 56 1993; 36 1995; 61 2009; 52 1973; 139 2003; 46 2003; 69 1994; 35 2011; 43 1995; 169 1988; 81 1996; 49 1983; 23 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_3_1 Berg HK (e_1_2_7_4_1) 1990; 39 e_1_2_7_9_1 Schaffzin DM (e_1_2_7_33_1) 2003; 69 e_1_2_7_8_1 e_1_2_7_7_1 Neilson OV (e_1_2_7_12_1) 1973; 139 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 Longo WE (e_1_2_7_23_1) 1995; 61 Wong MTC (e_1_2_7_29_1) 2011; 52 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_20_1 Bosset JF (e_1_2_7_31_1) 2006; 8 Li LR (e_1_2_7_28_1) 2006; 9 |
References_xml | – volume: 52 start-page: 211 year: 2009 end-page: 6 article-title: Cancer of the anus complicating perianal Crohn's disease publication-title: Dis Colon Rectum – volume: 49 start-page: 1517 year: 2001 article-title: In regard to Joon et al. IJROBP 1999;45:1199–1205 publication-title: Int J Radiat Oncol Biol Phys – volume: 36 start-page: 383 year: 1993 end-page: 7 article-title: Adenocarcinoma of the anal glands: results of a survey publication-title: Dis Colon Rectum – volume: 35 start-page: 347 year: 1994 end-page: 52 article-title: Lower gastrointestinal malignancy in Crohn's disease publication-title: Gut – volume: 89 start-page: 989 year: 1964 end-page: 94 article-title: Carcinoma associated with fistula in ano publication-title: Arch Surg – volume: 56 start-page: 1274 year: 2003 end-page: 83 article-title: Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network publication-title: Int J Radiat Oncol Biol Phys – volume: 80 start-page: 805 year: 1997 end-page: 15 article-title: The National Cancer Data Base report on carcinoma of the anus publication-title: Cancer – volume: 9 start-page: 402 year: 2006 end-page: 4 article-title: Clinical features and treatment of 49 patients with anal canal adenocarcinoma publication-title: Chin J Gastrointest Surg – volume: 85 start-page: 1686 year: 1999 end-page: 93 article-title: Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes publication-title: Cancer – volume: 52 start-page: 1375 year: 2009 end-page: 80 article-title: A twenty‐year experience with adenocarcinoma of the anal canal publication-title: Dis Colon Rectum – volume: 75 start-page: 352 year: 1957 end-page: 61 article-title: Relationship of anorectal disease to carcinoma publication-title: Arch Surg – volume: 81 start-page: 217 year: 1988 end-page: 9 article-title: Carcinoma in anal Crohn's disease: discussion paper publication-title: J R Soc Med – volume: 52 start-page: 9 year: 2011 end-page: 14 article-title: Anal canal malignancies: a review in an Asian population publication-title: SMJ – volume: 41 start-page: 992 year: 1998 end-page: 6 article-title: Carcinoma arising in anorectal fistulas of Crohn's disease publication-title: Dis Colon Rectum – volume: 39 start-page: 675 year: 1990 end-page: 8 article-title: Adenocarcinoma of the anal canal publication-title: Md Med J – volume: 169 start-page: 233 year: 1995 end-page: 7 article-title: Prognosis and recurrence patterns of anal adenocarcinoma publication-title: Am J Surg – volume: 23 start-page: 250 year: 1983 end-page: 4 article-title: Carcinoma of the anal gland: case report and review of the literature publication-title: J Surg Oncol – volume: 14 start-page: 66 year: 2010 end-page: 73 article-title: Malignant transformation in perianal fistulas of Crohn's disease: a systematic review of the literature publication-title: J Gastrointest Surg – volume: 101 start-page: 281 year: 2004 end-page: 8 article-title: Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973‐2000 publication-title: Cancer – volume: 55 start-page: 669 year: 2003 end-page: 78 article-title: Chemoradiation for adenocarcinoma of the anus publication-title: Int J Radiat Oncol Biol Phys – volume: 8 start-page: 283 year: 2006 end-page: 8 article-title: Effects of radiotherapy on different histopathological types of rectal carcinoma publication-title: Colorectal Dis – volume: 31 start-page: 268 year: 1988 end-page: 72 article-title: Adenocarcinoma of the anal ducts. A series of 21 cases publication-title: Dis Colon Rectum – volume: 8 start-page: 283 year: 2006 end-page: 8 article-title: Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results–EORTC 22921 publication-title: Colorectal Dis – volume: 69 start-page: 166 year: 2003 end-page: 9 article-title: Perianal mucinous adenocarcinoma: unusual case presentations and review of the literature publication-title: Am Surg – volume: 45 start-page: 1199 year: 1999 end-page: 205 article-title: Primary adenocarcinoma of the anus: a retrospective analysis publication-title: Int J Radiat Oncol Biol Phys – volume: 46 start-page: 1320 year: 2003 end-page: 4 article-title: Primary adenocarcinoma of the anus treated with combined modality therapy publication-title: Dis Colon Rectum – volume: 64 start-page: 218 year: 1997 end-page: 21 article-title: Perinal mucinous adenocarcinoma publication-title: J Surg Oncol – volume: 43 start-page: 36 year: 2011 end-page: 9 article-title: Adenocarcinomas associated with perineal fistulae in Crohn's disease have a rectal, not an anal, immunophenotype publication-title: Pathology – volume: 139 start-page: 299 year: 1973 end-page: 305 article-title: Carcinomas of the anorectal region of extramucosal origin with special reference to the anal ducts publication-title: Acta Chir Scand – volume: 61 start-page: 495 year: 1995 end-page: 500 article-title: Rare anal canal cancers in the U.S. veteran: patterns of disease and results of treatment publication-title: Am Surg – volume: 16 start-page: 1643 year: 2010 end-page: 8 article-title: Fistula‐associated anal adenocarcinoma in Crohn's disease publication-title: Inflamm Bowel Dis – volume: 49 start-page: 1009 year: 1996 end-page: 11 article-title: Adenocarcinoma of the anal glands publication-title: J Clin Pathol – ident: e_1_2_7_19_1 doi: 10.1007/BF02554358 – volume: 69 start-page: 166 year: 2003 ident: e_1_2_7_33_1 article-title: Perianal mucinous adenocarcinoma: unusual case presentations and review of the literature publication-title: Am Surg doi: 10.1177/000313480306900218 contributor: fullname: Schaffzin DM – ident: e_1_2_7_16_1 doi: 10.1007/BF02053944 – volume: 52 start-page: 9 year: 2011 ident: e_1_2_7_29_1 article-title: Anal canal malignancies: a review in an Asian population publication-title: SMJ contributor: fullname: Wong MTC – ident: e_1_2_7_17_1 doi: 10.1002/(SICI)1097-0142(19970815)80:4<805::AID-CNCR20>3.0.CO;2-W – ident: e_1_2_7_3_1 doi: 10.1016/S0002-9610(99)80143-3 – ident: e_1_2_7_21_1 doi: 10.1016/S0360-3016(99)00267-9 – ident: e_1_2_7_13_1 doi: 10.1002/ibd.21228 – volume: 8 start-page: 283 year: 2006 ident: e_1_2_7_31_1 article-title: Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results–EORTC 22921 publication-title: Colorectal Dis contributor: fullname: Bosset JF – ident: e_1_2_7_32_1 doi: 10.1111/j.1463-1318.2005.00934.x – ident: e_1_2_7_7_1 doi: 10.1002/jso.2930230407 – volume: 139 start-page: 299 year: 1973 ident: e_1_2_7_12_1 article-title: Carcinomas of the anorectal region of extramucosal origin with special reference to the anal ducts publication-title: Acta Chir Scand contributor: fullname: Neilson OV – ident: e_1_2_7_5_1 doi: 10.1001/archsurg.1957.01280150042005 – ident: e_1_2_7_2_1 doi: 10.1016/S0360-3016(02)04118-4 – ident: e_1_2_7_22_1 doi: 10.1016/S0360-3016(00)01540-6 – ident: e_1_2_7_30_1 doi: 10.1007/DCR.0b013e318197d0ad – ident: e_1_2_7_6_1 doi: 10.1001/archsurg.1964.01320060057011 – volume: 61 start-page: 495 year: 1995 ident: e_1_2_7_23_1 article-title: Rare anal canal cancers in the U.S. veteran: patterns of disease and results of treatment publication-title: Am Surg contributor: fullname: Longo WE – ident: e_1_2_7_8_1 doi: 10.1177/014107688808100411 – ident: e_1_2_7_10_1 doi: 10.1136/gut.35.3.347 – ident: e_1_2_7_26_1 doi: 10.1007/s10350-004-6740-9 – ident: e_1_2_7_18_1 doi: 10.1136/jcp.49.12.1009 – ident: e_1_2_7_20_1 doi: 10.1016/S0360-3016(03)00277-3 – volume: 9 start-page: 402 year: 2006 ident: e_1_2_7_28_1 article-title: Clinical features and treatment of 49 patients with anal canal adenocarcinoma publication-title: Chin J Gastrointest Surg contributor: fullname: Li LR – ident: e_1_2_7_14_1 doi: 10.1007/s11605-009-1061-x – ident: e_1_2_7_25_1 doi: 10.1002/(SICI)1097-0142(19990415)85:8<1686::AID-CNCR7>3.0.CO;2-7 – ident: e_1_2_7_15_1 doi: 10.1097/PAT.0b013e328340e4d6 – ident: e_1_2_7_27_1 doi: 10.1007/DCR.0b013e3181a79589 – ident: e_1_2_7_11_1 doi: 10.1002/cncr.20364 – ident: e_1_2_7_9_1 doi: 10.1007/BF02237388 – volume: 39 start-page: 675 year: 1990 ident: e_1_2_7_4_1 article-title: Adenocarcinoma of the anal canal publication-title: Md Med J contributor: fullname: Berg HK – ident: e_1_2_7_24_1 doi: 10.1002/(SICI)1096-9098(199703)64:3<218::AID-JSO8>3.0.CO;2-D |
SSID | ssj0016718 |
Score | 2.2807438 |
SecondaryResourceType | review_article |
Snippet | Aim
The prognosis of anal adenocarcinoma is poor and the management remains controversial. We carried out a literature review to identify current practice in... The prognosis of anal adenocarcinoma is poor and the management remains controversial. We carried out a literature review to identify current practice in the... Abstract Aim The prognosis of anal adenocarcinoma is poor and the management remains controversial. We carried out a literature review to identify current... AIMThe prognosis of anal adenocarcinoma is poor and the management remains controversial. We carried out a literature review to identify current practice in... |
SourceID | proquest crossref pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1481 |
SubjectTerms | abdominoperineal resection adenocarcinoma Adenocarcinoma - therapy Anal Anal Canal - surgery Anus Neoplasms - therapy chemo radiotherapy Chemoradiotherapy, Adjuvant - methods Chemotherapy, Adjuvant Humans Neoadjuvant Therapy - methods Neoplasm Recurrence, Local Prognosis Radiotherapy, Adjuvant Treatment Outcome |
Title | Adenocarcinoma of the anal canal - a systematic review |
URI | https://api.istex.fr/ark:/67375/WNG-4DFTQ72V-5/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcodi.12325 https://www.ncbi.nlm.nih.gov/pubmed/23809885 https://search.proquest.com/docview/1461339789 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwEA-iIL74_TG_qCg-CB1tk7Yp-DKccwpOlE33IiVJU5DhKvsA8cn_wf_Qv8S7dJ1ORNCX0tJLSe9yubvk7hdCDigiovAktSNJmc2Y59rS1cpWyuVCaN9NTXn0ZSOot9hF229PkeOiFibHhxgvuKFmmPkaFVzI_hclV1nyUEaHACvMXRpiPlf1Zowd5QahWdyDmQBUHoziCJsU03g-m05Yoxlk7PNPruak52pMT22B3BedzjNOOuXhQJbVyzc8x__-1SKZH_mkViUfREtkSneXyezlaNd9hfAKTE5g83rwmD0KK0stcBstgY2Uub6_vlnC-kSFtvKKmFXSqp02T-r26MQFWzFKfZwalZcEOlDSkyzRTHEnSrV0POkJSXFLUHAJAkxDHQUhhCNScDzjz2GCysSna2S6m3X1BrESxLpLwPxHAl4KjJScgGsKZBGLmFsi-wXn46ccWCMuAhJkQmyYUCKHRihjEtHrYCpa6Md3jbOYVWvN69C7jYFwr5BaDAqCux6iq7NhH2MbiMMhWI5KZD0X5_hr4K84EefQ-sgI5ZeexCdX1XNzt_kX4i0y5-EBGiYBZptMD3pDvQNuzEDumuH6AfAW6pc |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELdYK7G9DAaDlQELAvEwKVUSO4nzWLWUdrRFoBb6ZtmOI03Vkql_pGlPfAe-IZ9kd07aUoSQ2EuUKOcoucv9s8-_I-QdRUQUnmZuoihzGQt8V_lGu1r7XEoT-pndHj0cRb0Ju5iG06o2B_fClPgQmwk31Axrr1HBcUL6Ny3XRXrZxIgg3CN10HeKnRs6XzfoUX4U2-k9sAWg9OAWK3RSLOTZjt3xR3Vk7c3fgs3d2NU6n-6jssPqwmIWYs3JrLlaqqa-_QPR8d7f9ZgcVmGp0yr_oyPywORPyMNhtfD-lPAW2Cdwe3O4LK6kU2QORI6OxEHaHn_9-OlIZwsM7ZSbYo7JpPth3O65VdMFVzNKQ7SOOkgjE2kVKJYaprmXZEZ5gQqkorgqKLkCGWaxSaIYMhIlObb585ikKg3pM1LLi9ycECdFuLsUIoBEwk2JyZIXcUOBLGEJ8xvk7Zr14rrE1hDrnASZICwTGuS9lcqGRM5nWI0Wh-L76KNgne74Sxx8E0D4Zi02ATqCCx8yN8VqgekNpOKQLycN8ryU5-ZpELJ4Cecw-txK5R9vItqfO3179uJ_iM_Ifm88HIhBf_TplBwE2E_D1sO8JLXlfGVeQVSzVK_tv3sHmbPurw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9swED-yBMpeunbt1uxP57LRh4GD_8i2DHsJSdN0XdOttGtfhpBkGUpoHLIESp_2HfYN-0l2J8fJUsZgezE2Phn5Tnf3O-l0AngXUkUUnuVuqkLmMhb4rvKNdrX2uZQm8nO7PfpkEPcv2Mer6KoGH6q9MGV9iMWEG2mGtdek4OMs_03JdZFdtwgQRI-gwWKEvgSJzhbFo_w4sbN7aApQ59ErzouTUh7Psu2KO2oQZ2__hDVXoav1Pb0n8K3qdZlyMmzNpqql7x4UdPzf39qA9TkoddrlKNqEmhk9hbWT-bL7FvA2Wid0ehN8LG6kU-QO4kZHUiNtr_c_fjrSWZaFdsotMdtw0Ts47_Td-ZELrmZhGJFt1EEWm1irQLHMMM29NDfKC1QgVUhrgpIrlGCemDROMB5RktMhfx6Tocqi8BnUR8XI7ICTUbG7DP1_KvGlpFDJi7kJkSxlKfOb8LbivBiXlTVEFZEQE4RlQhP2rVAWJHIypFy0JBKXg0PBur3zL0nwVSDhXiU1gRpCyx5yZIrZdwpuMBDHaDltwvNSnIuvIWDxUs6x9XsrlL_0RHROu0f27sW_EL-Btc_dnvh0NDh-CY8DOkzDJsO8gvp0MjOvEdJM1a4dub8A2uPtXg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adenocarcinoma+of+the+anal+canal+-+a+systematic+review&rft.jtitle=Colorectal+disease&rft.au=Anwar%2C+S&rft.au=Welbourn%2C+H&rft.au=Hill%2C+J&rft.au=Sebag-Montefiore%2C+D&rft.date=2013-12-01&rft.eissn=1463-1318&rft.volume=15&rft.issue=12&rft.spage=1481&rft.epage=1488&rft_id=info:doi/10.1111%2Fcodi.12325&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-8910&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-8910&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-8910&client=summon |